Shorter RLS independently predicts CI in PWPD, particularly in milder‐stage patients, while PSH shows no association, and this nomogram may serve as a practical screening tool for CI in PWPD, pending external validation.
Abstract
ABSTRACT Aims To explore the associations of reproductive factors (RFs) and postmenopausal sex hormone (PSH) with cognitive impairment (CI) in postmenopausal women with PD (PWPD), and to develop a predictive nomogram. Methods Ninety‐five PWPD were divided into CI (n = 72; Montreal Cognitive Assessment [MoCA] < 26) and normal cognition (n = 23; MoCA ≥ 26) groups. RFs and serum PSH levels were collected. Risk factors were screened by logistic regression and confirmed via sensitivity and subgroup analyses. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis. Results Shorter reproductive lifespan (RLS) and lower education independently predicted CI in PWPD. Compared with RLS ≥ 39 years, RLS ≤ 32 years (adjusted OR = 12.41, p = 0.011) and 33–38 years (adjusted OR = 8.42, p = 0.008) were associated with significantly higher CI risks. The RLS‐CI association remained stable across sensitivity analyses and was more prominent in milder‐stage patients. No intergroup PSH differences were observed. A nomogram integrating RLS, education, age, disease duration, and Hoehn and Yahr stage (H&Y stage) demonstrated satisfactory discrimination (AUC = 0.903), calibration, and net benefit. Conclusion Shorter RLS independently predicts CI in PWPD, particularly in milder‐stage patients, while PSH shows no association. This nomogram may serve as a practical screening tool for CI in PWPD, pending external validation.
BACKGROUND
Early menarche, menopause, and short reproductive lifespan are risk factors for cardiovascular disease (CVD), but whether these reproductive characteristics are independently associated with CVD or influenced by obesity is unclear. This study aimed to address this gap.
METHODS
Postmenopausal women from the...
Jaclyn D. Borrowman, Hailey R. Banack, Claire E. Cook et al.· Journal of the American Hear...· 0 citations
Background Reproductive lifespan (RLS), the interval from menarche to natural menopause, has been associated with cardiovascular disease (CVD) risk. However, most prior studies have assumed a linear relationship, and the potential non-linearity of this association, as well as the underlying behavioral and biological me...
Jie Chen, Jia-Yu Shi, Qian Guo et al.· Frontiers in Medicine· 0 citations
AbstractObjectives: Menopause-related symptoms and hormonal changes may influence cardiovascular risk. We assessed demographic and menopause-related characteristics associated with SCORE2 risk in women aged 45–55 years.Materials and Methods: This retrospective observational study included 192 women. The primary outcome...
Sultan Can, M. Hocaoğlu, Ergul Demircivi et al.· Cukurova Anestezi ve Cerrahi...· 0 citations
OBJECTIVE
The association between premature menopause (age below 40 y) and subsequent risk of type 2 diabetes (T2D) is not fully understood. Sex hormone fluctuation due to ovarian function, hormone therapy (HT), and menopause-related changes in body composition may likely modify or mediate this relationship, which is t...
Yu Du, E. Leblanc, A. Shadyab et al.· Menopause· 0 citations
It is suggested that higher SHBG levels may reduce the risk of IS and could represent a potential therapeutic target, and further studies are needed to elucidate the mechanisms by which SHBG may confer protection against IS.
Among postmenopausal women, HIV infection was independently associated with a higher prevalence of carotid plaque, despite similar cIMT values between groups, and earlier menopause appeared to act as a cardiovascular risk amplifier in WLH.
P. R. da Silva, Vanessa V. P. Corrêa, João M. B. B. Ferreira et al.· Menopause· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.